pharmaceutical antitrust: unilateral conduct
Published 4 months ago • 65 plays • Length 9:50Download video MP4
Download video MP3
Similar videos
-
7:59
pharmaceutical antitrust: m&a
-
26:09
pharmaceutical antitrust: an analysis of us and eu law - overview
-
2:03
pharmaceutical antitrust: an analysis of us and eu law
-
1:00
pharmaceutical antitrust books presented by alec j. burnside (dechert) - global merger control
-
19:02
pharmaceutical antitrust: private enforcement
-
53:27
q&a: brian savage, vp & general counsel, antitrust & commercial litigation, teva pharmaceuticals
-
55:16
pharma alert: end of tirzepatide shortage (and the implications for your practice)
-
6:59
antitrust lawyer breaks down doj’s apple lawsuit | wsj
-
8:10
fooling the legal system and winning the case in usa!
-
48:31
2021 antitrust webinar series | boiling points: the role of hot documents in merger investigations
-
1:01:42
antitrust and innovation collide: insights for life sciences industries
-
1:06:23
antitrust annual seminar 2019: breakout ii: pharma pricing pitfalls
-
1:02:05
vertical mergers: assessing antitrust risk and maximizing clearance prospects
-
52:01
private antitrust litigation
-
27:50
antitrust brainstorming board session with daniel sokol
-
59:58
2021 antitrust webinar series | thriving in the new antitrust paradigm: part 2 – business practices
-
57:21
damitt 2022 year in review: global antitrust merger enforcement trends
-
1:04:13
antitrust annual seminar 2019: breakout iii: cutting-edge issues in merger clearance
-
1:46
antitrust laws (competition laws) explained in one minute: the sherman antitrust act, ftc act, etc.
-
1:03:31
damitt 2020 year in review: global antitrust merger enforcement trends amid pandemic